nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0869	0.136	CbGbCtD
Bezafibrate—SLCO1B1—Estradiol—osteoporosis	0.0763	0.12	CbGbCtD
Bezafibrate—CYP1A1—Cholecalciferol—osteoporosis	0.0694	0.109	CbGbCtD
Bezafibrate—CYP1A1—Estradiol—osteoporosis	0.0559	0.0879	CbGbCtD
Bezafibrate—CYP2C8—Raloxifene—osteoporosis	0.0519	0.0815	CbGbCtD
Bezafibrate—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0501	0.0787	CbGbCtD
Bezafibrate—CYP2C8—Cholecalciferol—osteoporosis	0.0401	0.0629	CbGbCtD
Bezafibrate—CYP2C8—Estradiol—osteoporosis	0.0323	0.0507	CbGbCtD
Bezafibrate—CYP3A4—Estropipate—osteoporosis	0.0315	0.0495	CbGbCtD
Bezafibrate—CYP3A4—Calcitriol—osteoporosis	0.0315	0.0495	CbGbCtD
Bezafibrate—CYP3A4—Ergocalciferol—osteoporosis	0.0252	0.0396	CbGbCtD
Bezafibrate—CYP3A4—Raloxifene—osteoporosis	0.021	0.033	CbGbCtD
Bezafibrate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0203	0.0319	CbGbCtD
Bezafibrate—CYP3A4—Cholecalciferol—osteoporosis	0.0162	0.0255	CbGbCtD
Bezafibrate—CYP3A4—Conjugated Estrogens—osteoporosis	0.0149	0.0234	CbGbCtD
Bezafibrate—CYP3A4—Estradiol—osteoporosis	0.0131	0.0206	CbGbCtD
Bezafibrate—Pharyngitis—Risedronate—osteoporosis	0.000663	0.00308	CcSEcCtD
Bezafibrate—Urinary tract disorder—Risedronate—osteoporosis	0.00066	0.00306	CcSEcCtD
Bezafibrate—Urethral disorder—Risedronate—osteoporosis	0.000655	0.00304	CcSEcCtD
Bezafibrate—Anaemia—Ibandronate—osteoporosis	0.000652	0.00302	CcSEcCtD
Bezafibrate—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000648	0.003	CcSEcCtD
Bezafibrate—Migraine—Estradiol—osteoporosis	0.000636	0.00295	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000632	0.00293	CcSEcCtD
Bezafibrate—Nausea—Calcium Acetate—osteoporosis	0.000628	0.00291	CcSEcCtD
Bezafibrate—Urinary tract disorder—Pamidronate—osteoporosis	0.000627	0.00291	CcSEcCtD
Bezafibrate—Myalgia—Estropipate—osteoporosis	0.000626	0.00291	CcSEcCtD
Bezafibrate—Urethral disorder—Pamidronate—osteoporosis	0.000623	0.00289	CcSEcCtD
Bezafibrate—Myalgia—Alendronate—osteoporosis	0.000617	0.00286	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000613	0.00284	CcSEcCtD
Bezafibrate—Dyspepsia—Etidronic acid—osteoporosis	0.000611	0.00283	CcSEcCtD
Bezafibrate—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.00061	0.00283	CcSEcCtD
Bezafibrate—Myalgia—Raloxifene—osteoporosis	0.000607	0.00281	CcSEcCtD
Bezafibrate—Alopecia—Ethinyl Estradiol—osteoporosis	0.000605	0.00281	CcSEcCtD
Bezafibrate—Myalgia—Ibandronate—osteoporosis	0.000601	0.00279	CcSEcCtD
Bezafibrate—Infection—Estropipate—osteoporosis	0.000597	0.00277	CcSEcCtD
Bezafibrate—Liver function test abnormal—Estradiol—osteoporosis	0.000597	0.00277	CcSEcCtD
Bezafibrate—Constipation—Etidronic acid—osteoporosis	0.000594	0.00275	CcSEcCtD
Bezafibrate—Myalgia—Calcitriol—osteoporosis	0.000588	0.00273	CcSEcCtD
Bezafibrate—Infection—Alendronate—osteoporosis	0.000588	0.00273	CcSEcCtD
Bezafibrate—Cramp muscle—Estradiol—osteoporosis	0.000582	0.0027	CcSEcCtD
Bezafibrate—Infection—Raloxifene—osteoporosis	0.000578	0.00268	CcSEcCtD
Bezafibrate—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000573	0.00266	CcSEcCtD
Bezafibrate—Flatulence—Risedronate—osteoporosis	0.000573	0.00266	CcSEcCtD
Bezafibrate—Urinary tract disorder—Zoledronate—osteoporosis	0.000573	0.00266	CcSEcCtD
Bezafibrate—Infection—Ibandronate—osteoporosis	0.000572	0.00265	CcSEcCtD
Bezafibrate—Gastritis—Estradiol—osteoporosis	0.000572	0.00265	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Estradiol—osteoporosis	0.00057	0.00264	CcSEcCtD
Bezafibrate—Thrombocytopenia—Raloxifene—osteoporosis	0.00057	0.00264	CcSEcCtD
Bezafibrate—Urethral disorder—Zoledronate—osteoporosis	0.000569	0.00264	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000568	0.00263	CcSEcCtD
Bezafibrate—Alopecia—Pamidronate—osteoporosis	0.000561	0.0026	CcSEcCtD
Bezafibrate—Muscle spasms—Risedronate—osteoporosis	0.000559	0.00259	CcSEcCtD
Bezafibrate—Influenza—Estradiol—osteoporosis	0.000558	0.00259	CcSEcCtD
Bezafibrate—Nausea—Ergocalciferol—osteoporosis	0.000555	0.00257	CcSEcCtD
Bezafibrate—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000554	0.00257	CcSEcCtD
Bezafibrate—Erythema—Pamidronate—osteoporosis	0.000553	0.00256	CcSEcCtD
Bezafibrate—Urticaria—Etidronic acid—osteoporosis	0.000551	0.00256	CcSEcCtD
Bezafibrate—Abdominal pain—Etidronic acid—osteoporosis	0.000549	0.00255	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000547	0.00254	CcSEcCtD
Bezafibrate—Insomnia—Estropipate—osteoporosis	0.000543	0.00252	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000539	0.0025	CcSEcCtD
Bezafibrate—Anaemia—Risedronate—osteoporosis	0.000537	0.00249	CcSEcCtD
Bezafibrate—Bronchitis—Estradiol—osteoporosis	0.000537	0.00249	CcSEcCtD
Bezafibrate—Muscle spasms—Pamidronate—osteoporosis	0.000531	0.00247	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00053	0.00246	CcSEcCtD
Bezafibrate—Dyspepsia—Estropipate—osteoporosis	0.000529	0.00245	CcSEcCtD
Bezafibrate—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000528	0.00245	CcSEcCtD
Bezafibrate—Insomnia—Raloxifene—osteoporosis	0.000526	0.00244	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000525	0.00243	CcSEcCtD
Bezafibrate—Insomnia—Ibandronate—osteoporosis	0.000521	0.00242	CcSEcCtD
Bezafibrate—Dyspepsia—Alendronate—osteoporosis	0.000521	0.00241	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000514	0.00238	CcSEcCtD
Bezafibrate—Pain—Estropipate—osteoporosis	0.000514	0.00238	CcSEcCtD
Bezafibrate—Constipation—Estropipate—osteoporosis	0.000514	0.00238	CcSEcCtD
Bezafibrate—Alopecia—Zoledronate—osteoporosis	0.000513	0.00238	CcSEcCtD
Bezafibrate—Dyspepsia—Raloxifene—osteoporosis	0.000512	0.00238	CcSEcCtD
Bezafibrate—Hypersensitivity—Etidronic acid—osteoporosis	0.000511	0.00237	CcSEcCtD
Bezafibrate—Anaemia—Pamidronate—osteoporosis	0.000511	0.00237	CcSEcCtD
Bezafibrate—Insomnia—Calcitriol—osteoporosis	0.00051	0.00236	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Estradiol—osteoporosis	0.00051	0.00236	CcSEcCtD
Bezafibrate—Dyspepsia—Ibandronate—osteoporosis	0.000507	0.00235	CcSEcCtD
Bezafibrate—Pain—Alendronate—osteoporosis	0.000506	0.00235	CcSEcCtD
Bezafibrate—Constipation—Alendronate—osteoporosis	0.000506	0.00235	CcSEcCtD
Bezafibrate—Erythema—Zoledronate—osteoporosis	0.000505	0.00234	CcSEcCtD
Bezafibrate—Pain—Raloxifene—osteoporosis	0.000497	0.00231	CcSEcCtD
Bezafibrate—Myalgia—Risedronate—osteoporosis	0.000495	0.0023	CcSEcCtD
Bezafibrate—Alopecia—Conjugated Estrogens—osteoporosis	0.000494	0.00229	CcSEcCtD
Bezafibrate—Pain—Ibandronate—osteoporosis	0.000492	0.00228	CcSEcCtD
Bezafibrate—Constipation—Ibandronate—osteoporosis	0.000492	0.00228	CcSEcCtD
Bezafibrate—Pruritus—Etidronic acid—osteoporosis	0.000491	0.00228	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Estropipate—osteoporosis	0.000491	0.00228	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Estradiol—osteoporosis	0.000491	0.00228	CcSEcCtD
Bezafibrate—Myocardial infarction—Estradiol—osteoporosis	0.000488	0.00226	CcSEcCtD
Bezafibrate—Erythema—Conjugated Estrogens—osteoporosis	0.000486	0.00226	CcSEcCtD
Bezafibrate—Muscle spasms—Zoledronate—osteoporosis	0.000485	0.00225	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Alendronate—osteoporosis	0.000484	0.00224	CcSEcCtD
Bezafibrate—Infection—Ethinyl Estradiol—osteoporosis	0.000484	0.00224	CcSEcCtD
Bezafibrate—Pain—Calcitriol—osteoporosis	0.000482	0.00224	CcSEcCtD
Bezafibrate—Constipation—Calcitriol—osteoporosis	0.000482	0.00224	CcSEcCtD
Bezafibrate—Flatulence—Conjugated Estrogens—osteoporosis	0.000479	0.00222	CcSEcCtD
Bezafibrate—Urticaria—Estropipate—osteoporosis	0.000477	0.00221	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Raloxifene—osteoporosis	0.000476	0.00221	CcSEcCtD
Bezafibrate—Diarrhoea—Etidronic acid—osteoporosis	0.000475	0.0022	CcSEcCtD
Bezafibrate—Abdominal pain—Estropipate—osteoporosis	0.000475	0.0022	CcSEcCtD
Bezafibrate—Infection—Risedronate—osteoporosis	0.000472	0.00219	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Ibandronate—osteoporosis	0.000471	0.00218	CcSEcCtD
Bezafibrate—Myalgia—Pamidronate—osteoporosis	0.000471	0.00218	CcSEcCtD
Bezafibrate—Urticaria—Alendronate—osteoporosis	0.00047	0.00218	CcSEcCtD
Bezafibrate—Abdominal pain—Alendronate—osteoporosis	0.000468	0.00217	CcSEcCtD
Bezafibrate—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000467	0.00217	CcSEcCtD
Bezafibrate—Anaemia—Zoledronate—osteoporosis	0.000467	0.00216	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Calcitriol—osteoporosis	0.000461	0.00214	CcSEcCtD
Bezafibrate—Abdominal pain—Raloxifene—osteoporosis	0.00046	0.00213	CcSEcCtD
Bezafibrate—Urticaria—Ibandronate—osteoporosis	0.000458	0.00212	CcSEcCtD
Bezafibrate—Abdominal pain—Ibandronate—osteoporosis	0.000455	0.00211	CcSEcCtD
Bezafibrate—Infection—Pamidronate—osteoporosis	0.000448	0.00208	CcSEcCtD
Bezafibrate—Urticaria—Calcitriol—osteoporosis	0.000448	0.00208	CcSEcCtD
Bezafibrate—Abdominal pain—Calcitriol—osteoporosis	0.000446	0.00207	CcSEcCtD
Bezafibrate—Pharyngitis—Estradiol—osteoporosis	0.000444	0.00206	CcSEcCtD
Bezafibrate—Hypersensitivity—Estropipate—osteoporosis	0.000442	0.00205	CcSEcCtD
Bezafibrate—Thrombocytopenia—Pamidronate—osteoporosis	0.000442	0.00205	CcSEcCtD
Bezafibrate—Urinary tract disorder—Estradiol—osteoporosis	0.000441	0.00205	CcSEcCtD
Bezafibrate—Urethral disorder—Estradiol—osteoporosis	0.000438	0.00203	CcSEcCtD
Bezafibrate—Rash—Etidronic acid—osteoporosis	0.000438	0.00203	CcSEcCtD
Bezafibrate—Dermatitis—Etidronic acid—osteoporosis	0.000437	0.00203	CcSEcCtD
Bezafibrate—Hypersensitivity—Alendronate—osteoporosis	0.000436	0.00202	CcSEcCtD
Bezafibrate—Headache—Etidronic acid—osteoporosis	0.000435	0.00202	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000432	0.00201	CcSEcCtD
Bezafibrate—Myalgia—Zoledronate—osteoporosis	0.00043	0.00199	CcSEcCtD
Bezafibrate—Insomnia—Risedronate—osteoporosis	0.000429	0.00199	CcSEcCtD
Bezafibrate—Pruritus—Estropipate—osteoporosis	0.000425	0.00197	CcSEcCtD
Bezafibrate—Hypersensitivity—Ibandronate—osteoporosis	0.000424	0.00197	CcSEcCtD
Bezafibrate—Erythema multiforme—Estradiol—osteoporosis	0.000423	0.00196	CcSEcCtD
Bezafibrate—Pruritus—Alendronate—osteoporosis	0.000418	0.00194	CcSEcCtD
Bezafibrate—Dyspepsia—Risedronate—osteoporosis	0.000418	0.00194	CcSEcCtD
Bezafibrate—Constipation—Ethinyl Estradiol—osteoporosis	0.000416	0.00193	CcSEcCtD
Bezafibrate—Hypersensitivity—Calcitriol—osteoporosis	0.000415	0.00193	CcSEcCtD
Bezafibrate—Myalgia—Conjugated Estrogens—osteoporosis	0.000414	0.00192	CcSEcCtD
Bezafibrate—Nausea—Etidronic acid—osteoporosis	0.000412	0.00191	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000411	0.00191	CcSEcCtD
Bezafibrate—Diarrhoea—Estropipate—osteoporosis	0.000411	0.00191	CcSEcCtD
Bezafibrate—Infection—Zoledronate—osteoporosis	0.000409	0.0019	CcSEcCtD
Bezafibrate—Insomnia—Pamidronate—osteoporosis	0.000408	0.00189	CcSEcCtD
Bezafibrate—Pruritus—Ibandronate—osteoporosis	0.000407	0.00189	CcSEcCtD
Bezafibrate—Pain—Risedronate—osteoporosis	0.000406	0.00188	CcSEcCtD
Bezafibrate—Constipation—Risedronate—osteoporosis	0.000406	0.00188	CcSEcCtD
Bezafibrate—Diarrhoea—Alendronate—osteoporosis	0.000405	0.00188	CcSEcCtD
Bezafibrate—Thrombocytopenia—Zoledronate—osteoporosis	0.000404	0.00187	CcSEcCtD
Bezafibrate—Pruritus—Calcitriol—osteoporosis	0.000399	0.00185	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000398	0.00185	CcSEcCtD
Bezafibrate—Diarrhoea—Raloxifene—osteoporosis	0.000398	0.00185	CcSEcCtD
Bezafibrate—Dyspepsia—Pamidronate—osteoporosis	0.000397	0.00184	CcSEcCtD
Bezafibrate—Dizziness—Estropipate—osteoporosis	0.000397	0.00184	CcSEcCtD
Bezafibrate—Alopecia—Estradiol—osteoporosis	0.000395	0.00183	CcSEcCtD
Bezafibrate—Infection—Conjugated Estrogens—osteoporosis	0.000394	0.00183	CcSEcCtD
Bezafibrate—Diarrhoea—Ibandronate—osteoporosis	0.000394	0.00183	CcSEcCtD
Bezafibrate—Dizziness—Alendronate—osteoporosis	0.000391	0.00181	CcSEcCtD
Bezafibrate—Erythema—Estradiol—osteoporosis	0.000389	0.0018	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Risedronate—osteoporosis	0.000388	0.0018	CcSEcCtD
Bezafibrate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000387	0.00179	CcSEcCtD
Bezafibrate—Pain—Pamidronate—osteoporosis	0.000386	0.00179	CcSEcCtD
Bezafibrate—Constipation—Pamidronate—osteoporosis	0.000386	0.00179	CcSEcCtD
Bezafibrate—Diarrhoea—Calcitriol—osteoporosis	0.000386	0.00179	CcSEcCtD
Bezafibrate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000385	0.00178	CcSEcCtD
Bezafibrate—Dizziness—Raloxifene—osteoporosis	0.000385	0.00178	CcSEcCtD
Bezafibrate—Flatulence—Estradiol—osteoporosis	0.000383	0.00178	CcSEcCtD
Bezafibrate—Dizziness—Ibandronate—osteoporosis	0.000381	0.00177	CcSEcCtD
Bezafibrate—Rash—Estropipate—osteoporosis	0.000379	0.00176	CcSEcCtD
Bezafibrate—Dermatitis—Estropipate—osteoporosis	0.000378	0.00175	CcSEcCtD
Bezafibrate—Urticaria—Risedronate—osteoporosis	0.000377	0.00175	CcSEcCtD
Bezafibrate—Headache—Estropipate—osteoporosis	0.000376	0.00174	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000375	0.00174	CcSEcCtD
Bezafibrate—Abdominal pain—Risedronate—osteoporosis	0.000375	0.00174	CcSEcCtD
Bezafibrate—Muscle spasms—Estradiol—osteoporosis	0.000374	0.00174	CcSEcCtD
Bezafibrate—Rash—Alendronate—osteoporosis	0.000373	0.00173	CcSEcCtD
Bezafibrate—Insomnia—Zoledronate—osteoporosis	0.000373	0.00173	CcSEcCtD
Bezafibrate—Dermatitis—Alendronate—osteoporosis	0.000373	0.00173	CcSEcCtD
Bezafibrate—Headache—Alendronate—osteoporosis	0.000371	0.00172	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Pamidronate—osteoporosis	0.000369	0.00171	CcSEcCtD
Bezafibrate—Rash—Raloxifene—osteoporosis	0.000367	0.0017	CcSEcCtD
Bezafibrate—Dermatitis—Raloxifene—osteoporosis	0.000366	0.0017	CcSEcCtD
Bezafibrate—Headache—Raloxifene—osteoporosis	0.000364	0.00169	CcSEcCtD
Bezafibrate—Rash—Ibandronate—osteoporosis	0.000363	0.00168	CcSEcCtD
Bezafibrate—Dermatitis—Ibandronate—osteoporosis	0.000363	0.00168	CcSEcCtD
Bezafibrate—Dyspepsia—Zoledronate—osteoporosis	0.000363	0.00168	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000362	0.00168	CcSEcCtD
Bezafibrate—Headache—Ibandronate—osteoporosis	0.000361	0.00167	CcSEcCtD
Bezafibrate—Insomnia—Conjugated Estrogens—osteoporosis	0.000359	0.00166	CcSEcCtD
Bezafibrate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000359	0.00166	CcSEcCtD
Bezafibrate—Nausea—Estropipate—osteoporosis	0.000357	0.00165	CcSEcCtD
Bezafibrate—Abdominal pain—Pamidronate—osteoporosis	0.000357	0.00165	CcSEcCtD
Bezafibrate—Rash—Calcitriol—osteoporosis	0.000355	0.00165	CcSEcCtD
Bezafibrate—Dermatitis—Calcitriol—osteoporosis	0.000355	0.00165	CcSEcCtD
Bezafibrate—Headache—Calcitriol—osteoporosis	0.000353	0.00164	CcSEcCtD
Bezafibrate—Pain—Zoledronate—osteoporosis	0.000352	0.00163	CcSEcCtD
Bezafibrate—Constipation—Zoledronate—osteoporosis	0.000352	0.00163	CcSEcCtD
Bezafibrate—Nausea—Alendronate—osteoporosis	0.000351	0.00163	CcSEcCtD
Bezafibrate—Hypersensitivity—Risedronate—osteoporosis	0.00035	0.00162	CcSEcCtD
Bezafibrate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000349	0.00162	CcSEcCtD
Bezafibrate—Nausea—Raloxifene—osteoporosis	0.000346	0.0016	CcSEcCtD
Bezafibrate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000344	0.0016	CcSEcCtD
Bezafibrate—Nausea—Ibandronate—osteoporosis	0.000342	0.00159	CcSEcCtD
Bezafibrate—Pain—Conjugated Estrogens—osteoporosis	0.000339	0.00157	CcSEcCtD
Bezafibrate—Constipation—Conjugated Estrogens—osteoporosis	0.000339	0.00157	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Zoledronate—osteoporosis	0.000337	0.00156	CcSEcCtD
Bezafibrate—Pruritus—Risedronate—osteoporosis	0.000336	0.00156	CcSEcCtD
Bezafibrate—Nausea—Calcitriol—osteoporosis	0.000335	0.00155	CcSEcCtD
Bezafibrate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000333	0.00154	CcSEcCtD
Bezafibrate—Hypersensitivity—Pamidronate—osteoporosis	0.000332	0.00154	CcSEcCtD
Bezafibrate—Myalgia—Estradiol—osteoporosis	0.000331	0.00154	CcSEcCtD
Bezafibrate—Urticaria—Zoledronate—osteoporosis	0.000327	0.00152	CcSEcCtD
Bezafibrate—Abdominal pain—Zoledronate—osteoporosis	0.000326	0.00151	CcSEcCtD
Bezafibrate—Diarrhoea—Risedronate—osteoporosis	0.000325	0.00151	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000324	0.0015	CcSEcCtD
Bezafibrate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000322	0.00149	CcSEcCtD
Bezafibrate—Pruritus—Pamidronate—osteoporosis	0.000319	0.00148	CcSEcCtD
Bezafibrate—Infection—Estradiol—osteoporosis	0.000316	0.00146	CcSEcCtD
Bezafibrate—Urticaria—Conjugated Estrogens—osteoporosis	0.000315	0.00146	CcSEcCtD
Bezafibrate—Dizziness—Risedronate—osteoporosis	0.000314	0.00146	CcSEcCtD
Bezafibrate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000314	0.00145	CcSEcCtD
Bezafibrate—Diarrhoea—Pamidronate—osteoporosis	0.000309	0.00143	CcSEcCtD
Bezafibrate—Rash—Ethinyl Estradiol—osteoporosis	0.000307	0.00142	CcSEcCtD
Bezafibrate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000307	0.00142	CcSEcCtD
Bezafibrate—Headache—Ethinyl Estradiol—osteoporosis	0.000305	0.00141	CcSEcCtD
Bezafibrate—Hypersensitivity—Zoledronate—osteoporosis	0.000304	0.00141	CcSEcCtD
Bezafibrate—Rash—Risedronate—osteoporosis	0.000299	0.00139	CcSEcCtD
Bezafibrate—Dermatitis—Risedronate—osteoporosis	0.000299	0.00139	CcSEcCtD
Bezafibrate—Dizziness—Pamidronate—osteoporosis	0.000298	0.00138	CcSEcCtD
Bezafibrate—Headache—Risedronate—osteoporosis	0.000297	0.00138	CcSEcCtD
Bezafibrate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000292	0.00136	CcSEcCtD
Bezafibrate—Pruritus—Zoledronate—osteoporosis	0.000292	0.00135	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000289	0.00134	CcSEcCtD
Bezafibrate—Nausea—Ethinyl Estradiol—osteoporosis	0.000289	0.00134	CcSEcCtD
Bezafibrate—Insomnia—Estradiol—osteoporosis	0.000287	0.00133	CcSEcCtD
Bezafibrate—Rash—Pamidronate—osteoporosis	0.000284	0.00132	CcSEcCtD
Bezafibrate—Dermatitis—Pamidronate—osteoporosis	0.000284	0.00132	CcSEcCtD
Bezafibrate—Headache—Pamidronate—osteoporosis	0.000283	0.00131	CcSEcCtD
Bezafibrate—Diarrhoea—Zoledronate—osteoporosis	0.000282	0.00131	CcSEcCtD
Bezafibrate—Nausea—Risedronate—osteoporosis	0.000282	0.00131	CcSEcCtD
Bezafibrate—Pruritus—Conjugated Estrogens—osteoporosis	0.000281	0.0013	CcSEcCtD
Bezafibrate—Dyspepsia—Estradiol—osteoporosis	0.00028	0.0013	CcSEcCtD
Bezafibrate—Dizziness—Zoledronate—osteoporosis	0.000273	0.00126	CcSEcCtD
Bezafibrate—Pain—Estradiol—osteoporosis	0.000272	0.00126	CcSEcCtD
Bezafibrate—Constipation—Estradiol—osteoporosis	0.000272	0.00126	CcSEcCtD
Bezafibrate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000272	0.00126	CcSEcCtD
Bezafibrate—Nausea—Pamidronate—osteoporosis	0.000268	0.00124	CcSEcCtD
Bezafibrate—Dizziness—Conjugated Estrogens—osteoporosis	0.000262	0.00122	CcSEcCtD
Bezafibrate—Rash—Zoledronate—osteoporosis	0.00026	0.00121	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Estradiol—osteoporosis	0.00026	0.0012	CcSEcCtD
Bezafibrate—Dermatitis—Zoledronate—osteoporosis	0.00026	0.0012	CcSEcCtD
Bezafibrate—Headache—Zoledronate—osteoporosis	0.000258	0.0012	CcSEcCtD
Bezafibrate—Urticaria—Estradiol—osteoporosis	0.000252	0.00117	CcSEcCtD
Bezafibrate—Abdominal pain—Estradiol—osteoporosis	0.000251	0.00116	CcSEcCtD
Bezafibrate—Rash—Conjugated Estrogens—osteoporosis	0.00025	0.00116	CcSEcCtD
Bezafibrate—Dermatitis—Conjugated Estrogens—osteoporosis	0.00025	0.00116	CcSEcCtD
Bezafibrate—Headache—Conjugated Estrogens—osteoporosis	0.000249	0.00115	CcSEcCtD
Bezafibrate—Nausea—Zoledronate—osteoporosis	0.000245	0.00114	CcSEcCtD
Bezafibrate—Nausea—Conjugated Estrogens—osteoporosis	0.000236	0.00109	CcSEcCtD
Bezafibrate—Hypersensitivity—Estradiol—osteoporosis	0.000234	0.00109	CcSEcCtD
Bezafibrate—Pruritus—Estradiol—osteoporosis	0.000225	0.00104	CcSEcCtD
Bezafibrate—Diarrhoea—Estradiol—osteoporosis	0.000217	0.00101	CcSEcCtD
Bezafibrate—Dizziness—Estradiol—osteoporosis	0.00021	0.000974	CcSEcCtD
Bezafibrate—Rash—Estradiol—osteoporosis	0.0002	0.000929	CcSEcCtD
Bezafibrate—Dermatitis—Estradiol—osteoporosis	0.0002	0.000928	CcSEcCtD
Bezafibrate—Headache—Estradiol—osteoporosis	0.000199	0.000923	CcSEcCtD
Bezafibrate—Nausea—Estradiol—osteoporosis	0.000189	0.000875	CcSEcCtD
Bezafibrate—PPARD—Metabolism—TPI1—osteoporosis	0.000111	0.000754	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PGLS—osteoporosis	0.000111	0.000751	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GPD2—osteoporosis	0.000111	0.000751	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000111	0.000749	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—IDH2—osteoporosis	0.000109	0.000739	CbGpPWpGaD
Bezafibrate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000106	0.000716	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—P4HB—osteoporosis	0.000105	0.000709	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR2—osteoporosis	0.000104	0.000704	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GAPDH—osteoporosis	0.000103	0.000696	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP27A1—osteoporosis	0.000103	0.000695	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PSMA2—osteoporosis	0.000103	0.000694	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PSMA5—osteoporosis	0.000103	0.000694	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	0.000102	0.00069	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000102	0.000689	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ATIC—osteoporosis	0.000102	0.000687	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PNP—osteoporosis	0.000102	0.000687	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000101	0.000687	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000101	0.000684	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000101	0.000681	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—RAP1A—osteoporosis	0.0001	0.000678	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—IDH2—osteoporosis	9.98e-05	0.000676	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ACP5—osteoporosis	9.98e-05	0.000676	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.85e-05	0.000667	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—RPL24—osteoporosis	9.7e-05	0.000657	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.56e-05	0.000648	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	9.55e-05	0.000647	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	9.47e-05	0.000642	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	9.47e-05	0.000642	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.44e-05	0.000639	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	9.42e-05	0.000638	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—IL6—osteoporosis	9.42e-05	0.000638	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP27A1—osteoporosis	9.38e-05	0.000635	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	9.35e-05	0.000633	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.32e-05	0.000631	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TPI1—osteoporosis	9.28e-05	0.000628	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—FDPS—osteoporosis	9.22e-05	0.000624	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PKM—osteoporosis	9.22e-05	0.000624	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	9.22e-05	0.000624	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR2—osteoporosis	9.16e-05	0.00062	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ACP5—osteoporosis	9.13e-05	0.000618	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.01e-05	0.00061	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TGFB1—osteoporosis	8.95e-05	0.000606	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—ESR1—osteoporosis	8.79e-05	0.000595	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.77e-05	0.000594	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPD2—osteoporosis	8.74e-05	0.000592	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PGLS—osteoporosis	8.74e-05	0.000592	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.73e-05	0.000591	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—P4HB—osteoporosis	8.72e-05	0.000591	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—LEP—osteoporosis	8.67e-05	0.000587	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—OXCT1—osteoporosis	8.63e-05	0.000584	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CA2—osteoporosis	8.63e-05	0.000584	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.6e-05	0.000582	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GAPDH—osteoporosis	8.56e-05	0.00058	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.55e-05	0.000579	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TPI1—osteoporosis	8.48e-05	0.000575	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MGLL—osteoporosis	8.41e-05	0.000569	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TNF—osteoporosis	8.36e-05	0.000566	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—RAP1A—osteoporosis	8.34e-05	0.000565	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—VDR—osteoporosis	8.25e-05	0.000558	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ENO1—osteoporosis	8.09e-05	0.000548	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PNP—osteoporosis	7.99e-05	0.000541	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ATIC—osteoporosis	7.99e-05	0.000541	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—P4HB—osteoporosis	7.98e-05	0.00054	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PSMA2—osteoporosis	7.97e-05	0.00054	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PSMA5—osteoporosis	7.97e-05	0.00054	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.93e-05	0.000537	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GAPDH—osteoporosis	7.83e-05	0.00053	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PSMA5—osteoporosis	7.81e-05	0.000529	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PSMA2—osteoporosis	7.81e-05	0.000529	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—RAP1A—osteoporosis	7.63e-05	0.000516	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.45e-05	0.000505	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.27e-05	0.000492	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—VDR—osteoporosis	7.27e-05	0.000492	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6R—osteoporosis	7.26e-05	0.000492	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—IDH2—osteoporosis	7.15e-05	0.000484	CbGpPWpGaD
Bezafibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7e-05	0.000474	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR2—osteoporosis	6.98e-05	0.000473	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.83e-05	0.000463	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—OXCT1—osteoporosis	6.8e-05	0.00046	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CA2—osteoporosis	6.8e-05	0.00046	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—IL6—osteoporosis	6.75e-05	0.000457	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ENO1—osteoporosis	6.74e-05	0.000456	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP27A1—osteoporosis	6.72e-05	0.000455	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.65e-05	0.00045	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—IL6—osteoporosis	6.64e-05	0.00045	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PSMA5—osteoporosis	6.64e-05	0.00045	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PSMA2—osteoporosis	6.64e-05	0.00045	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MGLL—osteoporosis	6.62e-05	0.000448	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ACP5—osteoporosis	6.54e-05	0.000443	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP19A1—osteoporosis	6.47e-05	0.000438	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.46e-05	0.000437	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.34e-05	0.000429	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR1—osteoporosis	6.3e-05	0.000427	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.25e-05	0.000423	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—LEP—osteoporosis	6.21e-05	0.000421	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ENO1—osteoporosis	6.17e-05	0.000417	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—POMC—osteoporosis	6.13e-05	0.000415	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TPI1—osteoporosis	6.08e-05	0.000412	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PSMA5—osteoporosis	6.07e-05	0.000411	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PSMA2—osteoporosis	6.07e-05	0.000411	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—osteoporosis	6e-05	0.000406	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.81e-05	0.000393	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PKM—osteoporosis	5.78e-05	0.000391	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FDPS—osteoporosis	5.78e-05	0.000391	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—P4HB—osteoporosis	5.72e-05	0.000387	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.68e-05	0.000384	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—IDH2—osteoporosis	5.63e-05	0.000381	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—POMC—osteoporosis	5.62e-05	0.00038	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GAPDH—osteoporosis	5.61e-05	0.00038	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PSMA5—osteoporosis	5.6e-05	0.000379	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PSMA2—osteoporosis	5.6e-05	0.000379	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR1—osteoporosis	5.56e-05	0.000376	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—VDR—osteoporosis	5.54e-05	0.000375	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PGLS—osteoporosis	5.48e-05	0.000371	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPD2—osteoporosis	5.48e-05	0.000371	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—RAP1A—osteoporosis	5.47e-05	0.00037	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP19A1—osteoporosis	5.39e-05	0.000365	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PKM—osteoporosis	5.3e-05	0.000359	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FDPS—osteoporosis	5.3e-05	0.000359	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP27A1—osteoporosis	5.29e-05	0.000358	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ADCY5—osteoporosis	5.29e-05	0.000358	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GPX1—osteoporosis	5.27e-05	0.000357	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6R—osteoporosis	5.21e-05	0.000353	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ACP5—osteoporosis	5.15e-05	0.000349	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.09e-05	0.000344	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PGLS—osteoporosis	5.02e-05	0.00034	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPD2—osteoporosis	5.02e-05	0.00034	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.02e-05	0.00034	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PNP—osteoporosis	5.01e-05	0.000339	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ATIC—osteoporosis	5.01e-05	0.000339	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR2—osteoporosis	5e-05	0.000339	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.95e-05	0.000335	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP19A1—osteoporosis	4.93e-05	0.000334	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—MTHFR—osteoporosis	4.86e-05	0.000329	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.85e-05	0.000329	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TPI1—osteoporosis	4.79e-05	0.000324	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.77e-05	0.000323	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—IL6—osteoporosis	4.76e-05	0.000322	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ATIC—osteoporosis	4.59e-05	0.000311	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PNP—osteoporosis	4.59e-05	0.000311	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—osteoporosis	4.57e-05	0.00031	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—P4HB—osteoporosis	4.5e-05	0.000305	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GAPDH—osteoporosis	4.42e-05	0.000299	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ENO1—osteoporosis	4.42e-05	0.000299	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ADCY5—osteoporosis	4.4e-05	0.000298	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GPX1—osteoporosis	4.39e-05	0.000297	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PSMA2—osteoporosis	4.35e-05	0.000295	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PSMA5—osteoporosis	4.35e-05	0.000295	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—RAP1A—osteoporosis	4.3e-05	0.000291	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TGFB1—osteoporosis	4.29e-05	0.000291	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA2—osteoporosis	4.26e-05	0.000288	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—OXCT1—osteoporosis	4.26e-05	0.000288	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR1—osteoporosis	4.23e-05	0.000287	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MGLL—osteoporosis	4.15e-05	0.000281	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—MTHFR—osteoporosis	4.05e-05	0.000274	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ADCY5—osteoporosis	4.03e-05	0.000273	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GPX1—osteoporosis	4.01e-05	0.000272	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—osteoporosis	4.01e-05	0.000272	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—VDR—osteoporosis	3.97e-05	0.000269	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.91e-05	0.000265	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—OXCT1—osteoporosis	3.91e-05	0.000264	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA2—osteoporosis	3.91e-05	0.000264	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—POMC—osteoporosis	3.89e-05	0.000263	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MGLL—osteoporosis	3.81e-05	0.000258	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.75e-05	0.000254	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—osteoporosis	3.7e-05	0.000251	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.59e-05	0.000243	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP19A1—osteoporosis	3.53e-05	0.000239	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—IDH2—osteoporosis	3.53e-05	0.000239	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ENO1—osteoporosis	3.48e-05	0.000236	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PSMA2—osteoporosis	3.43e-05	0.000232	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PSMA5—osteoporosis	3.43e-05	0.000232	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP27A1—osteoporosis	3.32e-05	0.000225	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—osteoporosis	3.28e-05	0.000222	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—POMC—osteoporosis	3.24e-05	0.000219	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—osteoporosis	3.24e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—IDH2—osteoporosis	3.24e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ACP5—osteoporosis	3.23e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.19e-05	0.000216	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—osteoporosis	3.08e-05	0.000208	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.04e-05	0.000206	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—osteoporosis	3.03e-05	0.000205	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—POMC—osteoporosis	3.01e-05	0.000204	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TPI1—osteoporosis	3e-05	0.000203	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—POMC—osteoporosis	2.96e-05	0.000201	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ACP5—osteoporosis	2.96e-05	0.0002	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.92e-05	0.000198	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—osteoporosis	2.89e-05	0.000196	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ADCY5—osteoporosis	2.89e-05	0.000195	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GPX1—osteoporosis	2.88e-05	0.000195	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—osteoporosis	2.87e-05	0.000195	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PKM—osteoporosis	2.84e-05	0.000193	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FDPS—osteoporosis	2.84e-05	0.000193	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—P4HB—osteoporosis	2.82e-05	0.000191	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.78e-05	0.000188	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GAPDH—osteoporosis	2.77e-05	0.000188	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TPI1—osteoporosis	2.75e-05	0.000186	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—RAP1A—osteoporosis	2.7e-05	0.000183	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PGLS—osteoporosis	2.7e-05	0.000183	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPD2—osteoporosis	2.7e-05	0.000183	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—osteoporosis	2.65e-05	0.00018	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—P4HB—osteoporosis	2.59e-05	0.000175	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GAPDH—osteoporosis	2.54e-05	0.000172	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RAP1A—osteoporosis	2.47e-05	0.000167	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ATIC—osteoporosis	2.47e-05	0.000167	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PNP—osteoporosis	2.47e-05	0.000167	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.35e-05	0.000159	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—osteoporosis	2.32e-05	0.000157	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ADCY5—osteoporosis	2.27e-05	0.000154	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPX1—osteoporosis	2.26e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—osteoporosis	2.2e-05	0.000149	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO1—osteoporosis	2.18e-05	0.000148	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.16e-05	0.000146	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMA5—osteoporosis	2.15e-05	0.000145	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PSMA2—osteoporosis	2.15e-05	0.000145	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POMC—osteoporosis	2.12e-05	0.000144	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—OXCT1—osteoporosis	2.1e-05	0.000142	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA2—osteoporosis	2.1e-05	0.000142	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—osteoporosis	2.09e-05	0.000142	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MGLL—osteoporosis	2.04e-05	0.000138	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO1—osteoporosis	2e-05	0.000135	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMA2—osteoporosis	1.97e-05	0.000133	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PSMA5—osteoporosis	1.97e-05	0.000133	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.74e-05	0.000118	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—IDH2—osteoporosis	1.74e-05	0.000118	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POMC—osteoporosis	1.67e-05	0.000113	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.000111	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.6e-05	0.000108	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACP5—osteoporosis	1.59e-05	0.000108	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—osteoporosis	1.58e-05	0.000107	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TPI1—osteoporosis	1.48e-05	0.0001	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADCY5—osteoporosis	1.42e-05	9.64e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPX1—osteoporosis	1.42e-05	9.61e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—P4HB—osteoporosis	1.39e-05	9.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GAPDH—osteoporosis	1.36e-05	9.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RAP1A—osteoporosis	1.33e-05	8.99e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—osteoporosis	1.31e-05	8.87e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADCY5—osteoporosis	1.31e-05	8.84e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPX1—osteoporosis	1.3e-05	8.81e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—osteoporosis	1.2e-05	8.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO1—osteoporosis	1.07e-05	7.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMA2—osteoporosis	1.06e-05	7.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PSMA5—osteoporosis	1.06e-05	7.16e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POMC—osteoporosis	1.05e-05	7.09e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POMC—osteoporosis	9.6e-06	6.5e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.58e-06	5.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADCY5—osteoporosis	7.01e-06	4.75e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX1—osteoporosis	6.99e-06	4.73e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—osteoporosis	6.45e-06	4.36e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POMC—osteoporosis	5.16e-06	3.49e-05	CbGpPWpGaD
